Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Reproductive Biomedicine Online|October 2, 2010
Development of humanized culture medium with plant-derived serum replacement for human pluripotent stem cellsMichaela Kunova, Kamil Matulka, Livia Eiselleova, et al.Stem Cells and Development|August 25, 2017
An Efficient Method for Generation of Knockout Human Embryonic Stem Cells Using CRISPR/Cas9 SystemDasa Bohaciakova, Tereza Renzova, Veronika Fedorova, et al.Stem Cells Translational Medicine|March 15, 2013
Adaptation to robust monolayer expansion produces human pluripotent stem cells with improved viabilityMichaela Kunova, Kamil Matulka, Livia Eiselleova, et al.Journal of Proteome Research|September 13, 2016
Proximity Labeling Reveals Molecular Determinants of FGFR4 Endosomal TransportEllen Margrethe Haugsten, Vigdis Sørensen, Michaela Kunova Bosakova, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|December 1, 2018
Freshwater Cyanotoxin Cylindrospermopsin Has Detrimental Stage-specific Effects on Hepatic Differentiation From Human Embryonic Stem CellsTereza Vanova, Jan Raska, Pavel Babica, et al.Frontiers in Physiology|September 16, 2016
MORN5 Expression during Craniofacial Development and Its Interaction with the BMP and TGFβ PathwaysPetra Cela, Marek Hampl, Katherine K Fu, et al.Scientific Reports|August 18, 2018
Colicin FY inhibits pathogenic Yersinia enterocolitica in miceJuraj Bosák, Lenka Micenková, Matěj Hrala, et al.Cellular Signalling|October 15, 2017
Proteomic analyses of signalling complexes associated with receptor tyrosine kinase identify novel members of fibroblast growth factor receptor 3 interactomeLukas Balek, Pavel Nemec, Peter Konik, et al.Oncotarget|January 10, 2018
Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480Iva Gudernova, Lukas Balek, Miroslav Varecha, et al.Human Molecular Genetics|October 24, 2015
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromesIva Gudernova, Iva Vesela, Lukas Balek, et al.Pageof 3